Transplantation of deprenyl-induced tyrosine hydroxylase-positive cells improves 6-OHDA-lesion rat model of Parkinson's disease: Behavioral and immunohistochemical evaluation

Cell Journal

Volumn 15, Issue 1, 2013, Pages 55-64

  Kashani, Maryam Haji Ghasem ^a   Ghorbanian, Mohammad Taghi ^a   Hosseinpour, Leili ^a  

^a DAMGHAN UNIVERSITY   (Iran)

Author keywords

6 Hydroxydopamine; Bone Marrow Stromal Cells; Cell Therapy; Deprenyl; Parkinson's Disease

Indexed keywords

APOMORPHINE; BROXURIDINE; OXIDOPAMINE; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LABELING; CELL TRANSPLANTATION; CELL ULTRASTRUCTURE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CULTURE MEDIUM; ELECTRON MICROSCOPY; EXPERIMENTAL STUDY; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; RAT; STROMA CELL;

EID: 84877251937     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Thomas MG, Stone L, Evill L, Ong S, Ziman M, Hool L. Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype. Transl Res. 2011; 157(2): 56-63.
2. Gardaneh M. Dopamine-synthesizing neurons: An overview of their development and application for cell therapy. Iran J Biotechnol 8. 2010; 8(4): 213-228.
3. Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, Cherlow T, et al. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. J Neural Transm Suppl. 2007; (72): 133-143.
4. Hellmann MA, Panet H, Barhum Y, Melamed E, Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopaminelesioned rodents. Neurosci Lett. 2006; 395(2): 124-128.
5. Wang X, Lu Y, Zhang H, Wang K, He Q, Wang Y, et al. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int J Dev Neurosci. 2004; 22(4): 175-183.
6. Folkerth RD, Durso R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology. 1996; 46(5): 1219-1225.
7. Kim HJ. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim Biophys Acta. 2011; 1812(1): 1-11.
8. Ma L, Liu Y, Zhang SC. Directed differentiation of dopamine neurons from human pluripotent stem cells. Methods Mol Biol. 2011; 767: 411-418.
9. Delcroix GJ, Garbayo E, Sindji L, Thomas O, Vanpouille-Box C, Schiller PC, et al. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats. Biomaterials. 2011; 32(6): 1560-1573.
10. Tatard VM, D'Ippolito G, Diabira S, Valeyev A, Hackman J, McCarthy M, et al. Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone. 2007; 40(2): 360-373.
11. Hall VJ, Li JY, Brundin P. Restorative cell therapy for Parkinson's disease: a quest for the perfect cell. Semin Cell Dev Biol. 2007; 18(6): 859-869.
12. Sensebé L, Bourin P. Mesenchymal stem cells - The challenge of a good therapeutic product. Med Sci (Paris). 2011; 27(3): 297-302.
13. Ghorbanian MT, Tirahi T, Mesbah-Namin SA, Fathellahi Y. Immunocytochemical study on the inductive effects of deprenyl on differentiation of BMSCs into dopaminergic neurons. Daneshvar Medicine. 2008; 15(73): 27-36.
14. Ghorbanian MT, Tarihi T, Mesbah-Namin AR. Evaluation the effect of deprenyl on the differentiation of rat's bone marrow stromal cells into dopamine producing neurons. Fayz. 2009; 12(3): 1-6.
15. Wang XD, Zhang HZ, Gong ZG, Yan XG, Lan Q,Huang Q. Neurotrophic effect of bone marrow stromal cells on proliferation and committed differentiation of ventral mesencephalic precursors. Clinl Oncol Cancer Res. 2011; 8(3): 170-174.
16. Lu L, Zhao C, Liu Y, Sun X, Duan C, Ji M, et al. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res Brain Res Protoc. 2005; 15(1): 46-51.
17. Tio M, Tan KH, Lee W, Wang TT, Udolph G. Roles of dbcAMP, IBMX and RA in aspects of neural differentiation of cord blood derived mesenchymal-like stem cells. PLoS One. 2010; 5(2): e9398.
18. Haji Ghasem Kashani M, Tiraihi T, Ghorbanian MT, Abrari K. In vitro expression of BDNF, GDNF, NGF, NT3 and NT4/5 genes in selegiline induced bone marrow stromal cells. Yakhteh Med J. 2010; 11(4): 400-407.
19. Ghorbanian MT, Tiraihi T, Mesbah-Namin SA, Fathollahi Y. Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype. Neurol Res. 2010; 32(2): 185-193.
20. Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, El ReFaey H, et al. Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases. Curr Drug Targets. 2006; 7(11): 1513-1529.
21. Magyar K, Szende B. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties. Neurotoxicology. 2004; 25(1-2): 233-242.
22. Semkova I, Wolz P, Schilling M, Krieglstein J. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur J Pharmacol. 1996; 315(1): 19-30.
23. He XJ, Uetsuka K, Nakayama H. Neural progenitor cells are protected against MPTP by MAO-B inhibitors. Neurotoxicology. 2008; 29(6): 1141-1146.
24. Rismanchi N, Floyd CL, Berman RF, Lyeth BG. Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols. Brain Res. 2003; 991(1-2): 46-55.
25. Barnabé GF, Schwindt TT, Calcagnotto ME, Motta FL, Martinez G Jr, de Oliveira AC, et al. Chemically-induced RAT mesenchymal stem cells adopt molecular properties of neuronal-like cells but do not have basic neuronal functional properties. PLoS One. 2009; 4(4): e5222.
26. Wislet-Gendebien S, Leprince P, Moonen G, Rogister B. Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci. 2003; 116(Pt 16): 3295-3302.
27. Ni WF, Yin LH, Lu J, Xu HZ, Chi YL, Wu JB, et al. In vitro neural differentiation of bone marrow stromal cells induced by cocultured olfactory ensheathing cells. Neurosci Lett. 2010; 475(2): 99-103.
28. Huang R, Han L, Li J, Ren F, Ke W, Jiang C, et al. Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles. J Gene Med. 2009; 11(9): 754-763.
29. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press; 204-206.
30. Blandini F, Cova L, Armentero MT, Zennaro E, Levandis G, Bossolasco P, et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 2010; 19(2): 203-217.
31. Shintani A, Nakao N, Kakishita K, Itakura T. Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice. J Neurosci Res. 2008; 86(13): 2829-2838.
32. Morizane A, Takahashi J, Shinoyama M, Ideguchi M, Takagi Y, Fukuda H, et al. Generation of graftable dopaminergic neuron progenitors from mouse ES cells by a combination of coculture and neurosphere methods. J Neurosci Res. 2006; 83(6): 1015-1027.
33. Yeu IS, Lee HJ, Yi Js, Yang JH, Lee IW, Lee HK. The survival and migration pattern of the bone marrow stromal cells after intracerebral transplantation in rats. J Korean Neurosurg Soc. 2004; 36: 400-404.
34. Nandoe Tewarie RD, Bossers K, Ritfeld GJ, Blits B, Grotenhuis JA, Verhaagen J, et al. Early passage bone marrow stromal cells express genes involved in nervous system development supporting their relevance for neural repair. Restor Neurol Neurosci. 2011; 29(3): 187-201.
35. Esmaeili F, Tiraihi T, Movahedin M, Mowla SJ. Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells. Rejuvenation Res. 2006; 9(4): 475-484.
36. Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int. 2008; 52(7): 1332-1342.